Cabotegravir/rilpivirine resistance in a patient living with HIV despite on-time administration: A case report
This case demonstrates the potential for patients living with HIV to develop resistance to CAB/RPV despite on-time administration of the medication. Proper administration and timing of antiretroviral therapy for these patients is essential to ensure efficacy and safety in the management of HIV but does not completely prevent development of resistance.
Authors
- Trent G. Towne
- Travis R. Hays
Institutions
- Regional Medical Center (US)
- Parkview Health (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1093/ajhp/zxaf078
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00